Available from: Garvey WT, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, et al
If you are pregnant and/or breastfeeding
LlewellynDCLogan EllisHAylwinSJOtarijaEGreenSSheridanWet alThe efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review
Ozempic maker takes biggest rival to court over weight-loss drug ads Novo Nordisk, the maker of Ozempic, is suing Eli Lilly over advertisements comparing some of their biggest-selling drugs
Find out more and book an appointment.
Unregulated Tissue Growth (BPC-157) LCY and BPC-157 are appealing in their ability to aid the healing process, but there has yet to be any large scale human trials approved for BPC-157 and the long term effects it has on cellular growth is mostly unknown